Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefotaxime-tazobactam vs cefotaxime-sulbactam in acute lower respiratory or urinary tract infections
CTR20140088Phase 3Active
- Sponsor
- Hainan Guoruitang Pharmaceutical
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cefotaxime + tazobactam in acute lower respiratory tract infection (LRTI), urinary tract infection (UTI), sponsored by Hainan Guoruitang Pharmaceutical. Started Apr 2014; status: active.
02
Drugs
cefotaxime + tazobactam
03
Conditions
acute lower respiratory tract infection (LRTI)urinary tract infection (UTI)
Beyond the preview
Go deeper on CTR20140088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140088.